Biomerieux SA EYWN-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 03/05/21 CET
105.90quote price arrow up+0.20 (+0.19%)
52 week range
76.65 - 144.70

...

Loading . . .

KEY STATS

  • Open105.90
  • Day High105.90
  • Day Low105.90
  • Prev Close105.70
  • 52 Week High144.70
  • 52 Week High Date08/10/20
  • 52 Week Low76.65
  • 52 Week Low Date03/12/20
  • Market Cap15,394.78M
  • Shares Out118.32M
  • 10 Day Average Volume72.18
  • Dividend0.19
  • Dividend Yield0.18%
  • Beta
  • 1 Year % Change23.79

RATIOS/PROFITABILITY

  • EPS (TTM)3.42
  • P/E (TTM)30.96
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date07/14/2020
  • Div Amount0.19
  • Split Date-
  • Split Factor-

Latest Biomerieux SA News

Latest EYWN-FF News From Our Partners

QUOTE FINDER

Profile

MORE
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the...
Alexandre Merieux
Chairman
Pierre Boulud
Chief Operating Officer
Guillaume Bouhours
Chief Financial Officer
Nicolas Cartier
Executive Vice President
Mark Miller
Executive Vice President
Address
376 chemin de l'Orme
Marcy-l Etoile
69280
France